Evidence map›Paper›PMID 33916986›Full record

ReviewInternational journal of molecular sciences2021

Future Perspectives in Detecting

Daniela Ferreira, Juliana Miranda, Paula Martins-Lopes, Filomena Adega, Raquel Chaves

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Daniela FerreiraBiosystems and Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisboa, 1749-016 Lisbon, Portugal.ORCID 0000-0002-7094-4969
Juliana MirandaBiosystems and Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisboa, 1749-016 Lisbon, Portugal.
Paula Martins-LopesBiosystems and Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisboa, 1749-016 Lisbon, Portugal.ORCID 0000-0001-8229-0117
Filomena AdegaBiosystems and Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisboa, 1749-016 Lisbon, Portugal.
Raquel ChavesBiosystems and Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisboa, 1749-016 Lisbon, Portugal.ORCID 0000-0002-5970-7428
University of Lisbon · PT

Funding

European Regional Development Fund NORTE-01-0247-FEDER-033533Fundação para a Ciência e a Tecnologia - FCT UID/MULTI/04046/2021 UID/MULTI/04046/2021
6 · The paper itself

Abstract

Non-small-cell lung cancer (NSCLC) is a major cause of death worldwide. Alterations in such genes as

Indexed as

Anaplastic Lymphoma KinaseBiomarkers, TumorBiopsyCarcinoma, Non-Small-Cell LungDiagnostic Tests, RoutineDrug Resistance, NeoplasmErbB ReceptorsHumansImmunohistochemistryLiquid BiopsyLung NeoplasmsMolecular Diagnostic TechniquesMutationOncogene Proteins, FusionPrognosisALK protein, humanAnaplastic Lymphoma KinaseBiomarkers, TumorEGFR protein, humanErbB ReceptorsOncogene Proteins, FusionALKEGFRliquid biopsiesnext-generation sequencingnon-small-cell lung cancerpredictive biomarkers

Identifiers

PMID33916986
PMCPMC8067613
OpenAlexW3152429537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.